Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The company will submit its comprehensive response on these observations to the US FDA
The company reported lifetime high EBIDTA of Rs. 250 crores
This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Subscribe To Our Newsletter & Stay Updated
